The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
Abstract
Lipoprotein transport across the blood–brain barrier (BBB) is of critical importance for the delivery of essential lipids to the brain cells. The occurrence of a low density lipoprotein (LDL) receptor on the BBB has recently been demonstrated. To examine further the function of this receptor, we have shown using an in vitro model of the BBB, that in contrast to acetylated LDL, which does not cross the BBB, LDL is specifically transcytosed across the monolayer. The C7 monoclonal antibody, known to interact with the LDL receptor-binding domain, totally blocked the transcytosis of LDL, suggesting that the transcytosis is mediated by the receptor. Furthermore, we have shown that cholesterol-depleted astrocytes upregulate the expression of the LDL receptor at the BBB. Under these conditions, we observed that the LDL transcytosis parallels the increase in the LDL receptor, indicating once more that the LDL is transcytosed by a receptor-mediated mechanism. The nondegradation of the LDL during the transcytosis indicates that the transcytotic pathway in brain capillary endothelial cells is different from the LDL receptor classical pathway. The switch between a recycling receptor to a transcytotic receptor cannot be explained by a modification of the internalization signals of the cytoplasmic domain of the receptor, since we have shown that LDL receptor messengers in growing brain capillary ECs (recycling LDL receptor) or differentiated cells (transcytotic receptor) are 100% identical, but we cannot exclude posttranslational modifications of the cytoplasmic domain, as demonstrated for the polymeric immunoglobulin receptor. Preliminary studies suggest that caveolae are likely to be involved in the potential transport of LDL from the blood to the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Blood-circulating LDL molecules can cross the blood-brain barrier in a process mediated by the LDLR expressed in caveolin- or clathrin-coated vesicles in specialized BBB-endothelial cells.
“Blood-circulating LDL molecules can also cross the BBB in a process mediated by the LDLR expressed in caveolin-or clathrin-coated vesicles in specialized BBB-endothelial cells.22”
From Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function (2024) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Dehouck, B., Dehouck, M. P., Fruchart, J. C., & Cecchelli, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.2.465 · Cited by 240
Self-citation
Flagged first, then by citations
Research works printed but not linked: 58
- Albers, 1992, Cholesteryl ester transfer protein in human brain, Int J Clin Lab Res, 21, 264, 10.1007/BF02591657 · DOI
- Anderson, 1993, Plasmalemmal caveolae and GPI-anchored membrane proteins, Curr Opin Cell Biol, 5, 647, 10.1016/0955-0674(93)90135-D · DOI
- Aroeti, 1994, Polarized sorting of the polymeric immunoglobulin receptor in the exocytotic and endocytotic pathways is controlled by the same amino acids, EMBO (Eur Mol Biol Organ) J, 13, 2297, 10.1002/j.1460-2075.1994.tb06513.x · DOI · Paper page
- Basu, 1976, Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts, Proc Natl Acad Sci USA, 73, 493, 10.1073/pnas.73.9.3178 · DOI
- Beisiegel, 1981, Monoclonal antibodies to the low-density lipoprotein receptor as a probe to study of receptor mediated endocytosis and the genetics of familial hypercholesterolemia, J Biol Chem, 256, 11923, 10.1016/S0021-9258(19)68494-2 · DOI · Paper page
- Bénistant, 1995, Fatty acid composition of brain capillary endothelial cells: effect of the coculture with astrocytes, J Lipid Res, 36, 1, 10.1016/S0022-2275(20)39712-1 · DOI
- Betz, 1978, Polarity of the blood-brain barrier: neutral amino-acid transport into isolated brain capillaries, Science (Wash DC), 202, 225, 10.1126/science.211586 · DOI
- Bilheimer, 1972, The metabolism of very low density lipoproteins, Biochem Biophys Acta, 260, 212, 10.1016/0005-2760(72)90034-3 · DOI
- Booher, 1972, Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures, Neurobiology, 2, 97
- Bornstein, 1958, Reconstituted rat tail collagen used as substrate for time tissue cultures on coverslips in Maximow slides and roller tubes, Lab Invest, 7, 134
- Brecher, 1979, Lipoprotein lipase and acid lipase activity in rabbit brain microvessels, J Lipid Res, 20, 464, 10.1016/S0022-2275(20)40600-5 · DOI
- Broadwell, 1994, Ferrotransferrin and antibody against the transferrin receptor as potential vehicles for drug delivery across the mammalian blood-brain barrier into the CNS, Methods Neurosci, 21, 93, 10.1016/B978-0-12-185291-7.50012-6 · DOI
- Bundgaard, 1983, Vesicular transport in capillary endothelium: does it occur?, FEBS (Fed Eur Biochem Soc) Proc Meet Fed Proc, 42, 2425
- Casanova, 1990, Phosphorylation of the polymeric immunoglobulin receptor required for its efficient transcytosis, Science (Wash DC), 248, 742, 10.1126/science.2110383 · DOI
- Dehouck, 1990, An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro, J Neurochem, 54, 1798, 10.1111/j.1471-4159.1990.tb01236.x · DOI
- Dehouck, 1990, The blood-brain barrier in vitro: coculture of brain capillary endothelial cells and astrocytes, Circulation et Métabolisme du Cerveau, 7, 151
- Dehouck, 1992, Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models, J Neurochem, 58, 1790, 10.1111/j.1471-4159.1992.tb10055.x · DOI
- Dehouck, 1995, Drug transport to the brain: comparison between in vitro and in vivo models of the blood-brain barrier, Eur J Pharm Sci, 3, 357, 10.1016/0928-0987(95)00028-5 · DOI
- Descamps, 1996, Receptor- mediated transcytosis of transferrin through blood-brain barrier endothelial cells, Am J Physiol, 270, H1149
- Eker, 1994, Selective regulation of apical endocytosis in polarized Madin-Darby canine kidney cells by mastosporan and cAMP, J Biol Chem, 269, 18607, 10.1016/S0021-9258(17)32353-0 · DOI
- Franck, 1981, A direct in vitro demonstration of insulin binding to isolated capillaries, Diabetes, 30, 757, 10.2337/diab.30.9.757 · DOI
- Franck, 1985, Enhanced insulin binding to blood-brain barrier in vivo and to brain microvessels in vitro in newborn rabbits, Diabetes, 34, 728, 10.2337/diab.34.8.728 · DOI
- Friden, 1991, Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier, Proc Natl Acad Sci USA, 88, 4771, 10.1073/pnas.88.11.4771 · DOI
- Friden, 1993, Blood-brain barrier penetration and in vivo activity of an NGF conjugate, Science (Wash DC), 259, 373, 10.1126/science.8420006 · DOI
- Ghitescu, 1986, Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis, J Cell Biol, 102, 1304, 10.1083/jcb.102.4.1304 · DOI
- Gospodarowicz, 1986, Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex, and corpus luteum capillaries, J Cell Physiol, 127, 121, 10.1002/jcp.1041270116 · DOI
- Handley, 1981, Hepatic binding and internalization of low density lipoprotein-gold conjugates in rats treated with 17 a-ethinyl estradiol, J Cell Biol, 90, 778, 10.1083/jcb.90.3.778 · DOI
- Hoff, 1978, ApoB concentration in the normal aorta, Biochem Biophys Res Commun, 85, 1424, 10.1016/0006-291X(78)91162-2 · DOI
- King, 1985, Receptor-mediated transport of insulin across endothelial cells, Science (Wash DC), 227, 1583, 10.1126/science.3883490 · DOI
- Lamaze, 1995, The emergence of clathrin-independent pinocytic pathways, Curr Opin Cell Biol, 7, 573, 10.1016/0955-0674(95)80015-8 · DOI
- Langeler, 1989, Passage of low density lipoproteins through monolayers of human arterial endothelial cells. Effects of vasoactive substances in an in vitro model, Arteriosclerosis, 9, 550, 10.1161/01.ATV.9.4.550 · DOI
- Li, 1991, Low density lipoprotein receptors on epithelial cell (Madin-Darby Canine Kidney) monolayers, J Biol Chem, 266, 9263, 10.1016/S0021-9258(18)31579-5 · DOI
- Lisanti, 1994, Characterization of caveolin-rich membrane domains isolated from an endothelial rich source: implications for human disease, J Cell Biol, 126, 111, 10.1083/jcb.126.1.111 · DOI
- Malavolti, 1991, Cerebral low-density lipoprotein (LDL) uptake is stimulated by acute bile drainage, Biochem Biophys Acta, 1081, 106, 10.1016/0005-2760(91)90257-I · DOI
- Matter, 1993, Common signals control low density lipoprotein receptor sorting in endosomes and the Golgi complex of MDCK cells, Cell, 74, 1053, 10.1016/0092-8674(93)90727-8 · DOI · Paper page
- McGookey, 1983, Filipin–cholesterol complexes form in uncoated vesicle membrane derived from coated vesicles during receptor-mediated endocytosis of low density lipoprotein, J Cell Biol, 96, 1273, 10.1083/jcb.96.5.1273 · DOI
- Mellman, 1984, Internalization and rapid recycling of macrophages Fc receptors tagged with monovalent antireceptor antibody: possible role of prelysosomal compartment, J Cell Biol, 98, 1163, 10.1083/jcb.98.4.1163 · DOI
- Méresse, 1989, Low-density lipoprotein receptor on endothelium of brain capillaries, J Neurochem, 53, 340, 10.1111/j.1471-4159.1989.tb07340.x · DOI · Paper page
- Méresse, 1989, Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture, J Neurochem, 53, 1363, 10.1111/j.1471-4159.1989.tb08526.x · DOI
- Milici, 1987, Transcytosis of albumin in capillary endothelium, J Cell Biol, 105, 2603, 10.1083/jcb.105.6.2603 · DOI
- Montesano, 1982, Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins, Nature (Lond), 296, 651, 10.1038/296651a0 · DOI
- Navab, 1986, Rabbit β-migrating very low density lipoprotein increases endothelial macromolecular transport without altering electrical resistance, J Clin Invest, 5, 135
- Pardridge, 1985, Absence of albumin receptor on brain capillaries in vivo and vitro, Am J Physiol, 249, E264
- Parton, 1994, Regulated internalization of caveolae, J Cell Biol, 127, 1199, 10.1083/jcb.127.5.1199 · DOI
- Russell, 1984, Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor, Cell, 37, 577, 10.1016/0092-8674(84)90388-X · DOI · Paper page
- Salen, 1973, Metabolism of cholestanol, cholesterol, and bile acid in cerebrotendinous xanthomatosis, J Clin Invest, 52, 2822, 10.1172/JCI107478 · DOI
- Salen, 1987, Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis, N Engl J Med, 316, 1233, 10.1056/NEJM198705143162002 · DOI
- Severs, 1986, Caveolar bands and the effects of sterol-binding agents in vascular smooth muscle plasma membranes, Lab Invest, 55, 295
- Schnitzer, 1994, Albondin-mediated capillary permeability to albumin, J Biol Chem, 269, 6072, 10.1016/S0021-9258(17)37571-3 · DOI
- Schnitzer, 1994, Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules, J Cell Biol, 127, 1217, 10.1083/jcb.127.5.1217 · DOI
- Smart, 1995, Hormonal regulation of caveolae internalization, J Cell Biol, 131, 929, 10.1083/jcb.131.4.929 · DOI
- Smith, 1983, Low density lipoprotein concentration in interstitial fluid from human atherosclerotic lesions, Biochem Biophys Acta, 754, 249, 10.1016/0005-2760(83)90139-X · DOI
- Traber, 1984, Vitamin E is delivered to cells via the high affinity receptor for low density lipoprotein, Am J Clin Nutr, 40, 747, 10.1093/ajcn/40.4.747 · DOI
- Tran, 1987, Ligands internalized through coated or non-coated invaginations follow a common intracellular pathway, Proc Natl Acad Sci USA, 84, 7957, 10.1073/pnas.84.22.7957 · DOI
- Vasile, 1983, Visualization of the binding, endocytosis of low density lipoprotein in the arterial endothelium in situ, J Cell Biol, 96, 1677, 10.1083/jcb.96.6.1677 · DOI
- Van Houtten, 1979, Insulin binds to brain blood vessels in vivo, Nature (Lond), 282, 623, 10.1038/282623a0 · DOI · Paper page
- Villegas, 1993, Transcytosis of protein through the mammalian cerebral epithelium. II. Adsorptive transcytosis of WGA-HP and the blood-brain and brain-blood barriers, J Neurocytol, 22, 67, 10.1007/BF01181571 · DOI
- Wolf, 1992, Characterization and immunohistochemical localization of α2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain, Am J Pathol, 141, 37
Cited by
Sorted by citations
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Brain Cholesterol: Long Secret Life Behind a Barrier
Björkhem, I., & Meaney, S. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000120374.59826.1b · Cited by 1,044
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771
Transcytosis: Crossing Cellular Barriers
TUMA, P. L., & HUBBARD, A. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00001.2003 · Cited by 681
Solid lipid nanoparticles for targeted brain drug delivery.
BLASI, P., GIOVAGNOLI, S., SCHOUBBEN, A., RICCI, M., & ROSSI, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.011 · Cited by 506
Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles
Saint-Pol, J., Gosselet, F., Duban-Deweer, S., Pottiez, G., & Karamanos, Y. (2020) · Cells · doi:10.3390/cells9040851 · Cited by 503
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
Lajoie, J. M., & Shusta, E. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124852 · Cited by 399
Central nervous system: cholesterol turnover, brain development and neurodegeneration
Dietschy, J. M. (2009) · bchm · doi:10.1515/bc.2009.035 · Cited by 394
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
S. Hersh, D., S. Wadajkar, A., B. Roberts, N., G. Perez, J., P. Connolly, N., Frenkel, V., A. Winkles, J., F. Woodworth, G., & J. Kim, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151221150733 · Cited by 387
Regulation of Ketone Body Metabolism and the Role of PPARα
Grabacka, M., Pierzchalska, M., Dean, M., & Reiss, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122093 · Cited by 305
Mackic, J. B., Stins, M., McComb, J. G., Calero, M., Ghiso, J., Kim, K. S., Yan, S. D., Stern, D., Schmidt, A. M., Frangione, B., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2029 · Cited by 242
Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219
Georgieva, J., Hoekstra, D., & Zuhorn, I. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6040557 · Cited by 211
Ribecco-Lutkiewicz, M., Sodja, C., Haukenfrers, J., Haqqani, A. S., Ly, D., Zachar, P., Baumann, E., Ball, M., Huang, J., Rukhlova, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19522-8 · Cited by 148
Fung, K. Y., Wang, C., Nyegaard, S., Heit, B., Fairn, G. D., & Lee, W. L. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00841 · Cited by 129
Candela, P., Gosselet, F., Miller, F., Buee-Scherrer, V., Torpier, G., Cecchelli, R., & Fenart, L. (2008) · Endothelium · doi:10.1080/10623320802487759 · Cited by 117
Self-citationTargeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases
Anthony, D. P., Hegde, M., Shetty, S. S., Rafic, T., Mutalik, S., & Rao, B. S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119326 · Cited by 110
Enhancing autophagy in Alzheimer's disease through drug repositioning
Eshraghi, M., Ahmadi, M., Afshar, S., Lorzadeh, S., Adlimoghaddam, A., Rezvani Jalal, N., West, R., Dastghaib, S., Igder, S., Torshizi, S. R. N., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108171 · Cited by 89
Transcellular transport of CCL2 across brain microvascular endothelial cells
Ge, S., Song, L., Serwanski, D. R., Kuziel, W. A., & Pachter, J. S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05056.x · Cited by 83
Chen, Y., Chen, K., Zhang, J., Li, X., Shu, N., Wang, J., Zhang, Z., & Reiman, E. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.302 · Cited by 67
Wang, S.-H., Huang, Y., Yuan, Y., Xia, W.-Q., Wang, P., & Huang, R. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-175 · Cited by 44
Mulder, M., & Terwel, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022429 · Cited by 40
Borrell-Pages, M., Luquero, A., Vilahur, G., Padró, T., & Badimon, L. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvad159 · Cited by 10
Mazura, A. D., & Pietrzik, C. U. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041268 · Cited by 9
“Since enriched protein levels available at the luminal surface as well as rapid and efficient blood-to-brain transcytosis rates across the BBB are important characteristics of a potential vehicle receptor, the common targets are non-microvascularspecific metabolic receptors for insulin [45], transferrin [46], insulin-…”
Background
Metadata
- Authors
- Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R.
- Affiliations
- *Institut National de la Santé et de la Recherche Médicale U325, Department of Atherosclerosis Institut Pasteur, 59000 Lille, France; and ‡Laboratoire de Chimie biologique (UMR 111), Université des Sciences et Technologies de Lille I, 59655 Villeneuve d'Ascq Cédex, France
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 1997-08-25
- Volume
- 138
- Issue
- 4
- Pages
- 877-889
- ISSN
- 0021-9525
- 1540-8140
- PMC
- PMC2138047
- Cited by
- 490
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review